Atrás
Rango del Día
$20.90
$24.70
Rango de 52 Semanas
$17.62
$28.10
Volumen
92
Promedio 50D / 200D
$25.37
/
$25.54
Cierre Anterior
$24.70
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 91.9 | 0.3 |
| P/B | 4.4 | 2.9 |
| ROE % | 4.7 | 3.7 |
| Net Margin % | 3.3 | 3.8 |
| Rev Growth 5Y % | 7.0 | 10.0 |
| D/E | 0.5 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$1.09
$1.06 – $1.13
|
290 M | 1 |
| FY2027 |
$0.97
$0.95 – $1.01
|
270 M | 1 |
| FY2026 |
$0.87
$0.84 – $0.90
|
250 M | 1 |
Puntos Clave
Revenue grew 7.01% annually over 5 years — modest growth
Earnings grew 162.77% over the past year
ROE of 4.74% is below average
Debt/Equity of 0.49 — conservative balance sheet
Generating 15.65M in free cash flow
P/E of 91.85 — premium valuation
Crecimiento
Revenue Growth (5Y)
7.01%
Revenue (1Y)-12.64%
Earnings (1Y)162.77%
FCF Growth (3Y)N/A
Calidad
Return on Equity
4.74%
ROIC7.09%
Net Margin3.28%
Op. Margin9.75%
Seguridad
Debt / Equity
0.49
Current Ratio2.39
Interest Coverage5.19
Valoración
P/E Ratio
91.85
P/B Ratio4.35
EV/EBITDA33.82
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.64% | Revenue Growth (3Y) | -0.73% |
| Earnings Growth (1Y) | 162.77% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.01% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 240.24M | Net Income (TTM) | 7.88M |
| ROE | 4.74% | ROA | 2.51% |
| Gross Margin | 41.00% | Operating Margin | 9.75% |
| Net Margin | 3.28% | Free Cash Flow (TTM) | 15.65M |
| ROIC | 7.09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 2.39 |
| Interest Coverage | 5.19 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 91.85 | P/B Ratio | 4.35 |
| P/S Ratio | 3.01 | PEG Ratio | 0.62 |
| EV/EBITDA | 33.82 | Dividend Yield | 0.01% |
| Market Cap | 724.04M | Enterprise Value | 791.94M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 240.24M | 275.00M | 243.80M | 228.58M | 183.22M |
| Net Income | 7.88M | 3.00M | -14.40M | -6.81M | -25.28M |
| EPS (Diluted) | 0.26 | 0.10 | -0.48 | -0.25 | -0.83 |
| Gross Profit | 98.50M | 105.80M | 85.90M | 66.10M | 59.83M |
| Operating Income | 23.42M | 10.70M | -12.60M | 9.85M | -7.38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 314.32M | 312.90M | 348.10M | 344.90M | 399.42M |
| Total Liabilities | 147.87M | 146.40M | 188.70M | 136.28M | 193.65M |
| Shareholders' Equity | 166.45M | 166.50M | 159.40M | 210.50M | 205.77M |
| Total Debt | 81.28M | 79.40M | 98.60M | 77.50M | 70.13M |
| Cash & Equivalents | 13.38M | 14.00M | 13.20M | 9.50M | 14.13M |
| Current Assets | 121.02M | 106.30M | 126.20M | 110.10M | 129.13M |
| Current Liabilities | 50.72M | 46.90M | 40.00M | 47.10M | 47.59M |